Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer. (May 2021)

• Record Type: Journal Article
• Authors: Wang, Kevin Y; Newman, James; Lee, Chung-Shien; Seetharamu, Nagashree
• Is Part Of: SAGE open medicine. Volume 9(2021)
• Publication Date: 2021-05
• Subjects: Breast cancer -- lung cancer -- radiation -- surgery -- chemotherapy -- estrogen receptor (ER) -- progesterone receptor (PR) -- HER2 receptor -- EGFR -- BRCA -- TP53; Medicine -- Periodicals; 610.5
• DOI: 10.1177/20503121211017757
• Languages: English
• ISSNs: 2050-3121

Abstract

Breast cancer is the most common malignancy in women, and lung cancer, the leading cause of cancer-related mortality in the United States, is the most common subsequent primary cancer among breast cancer survivors. In this review, we examine the risk factors that cause subsequent primary lung cancer after breast cancer (referred to herein as BCLC patients) as well as the prognostic factors that may affect survival. Notable clinicopathological features include patient characteristics such as age, smoking history, and the presence of EGFR or BRCA mutations, as well as factors related to the treatment of breast cancer such as radiation, surgery, chemotherapy, stage, anti-estrogen therapy, and ER/PR/HER2 status.